Bucco
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80041815
- Status
- Active licence
- Licence date
- 19 April 2013
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ononis spinosa Source : Racine Extraction ratio : 1:7 Dry plant equivalent : 0.05 g | 0.35 mL | Not calculated |
| Glycyrrhiza glabra Source : Racine Extraction ratio : 1:7 Dry plant equivalent : 0.05 g | 0.35 mL | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille Extract : Matériel brut sec Extraction ratio : 1:7 Dry plant equivalent : 0.05 g | 0.35 mL | Not calculated |
| Salix alba Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 1:7 Dry plant equivalent : 0.05 g | 0.35 mL | Not calculated |
| Mentha x piperita Source : Feuille Extract : Matériel brut sec Extraction ratio : 1:7.03 Dry plant equivalent : 0.0825 g | 0.58 mL | Not calculated |
| Equisetum arvense Source : Parties aériennes Extraction ratio : 1:7 Dry plant equivalent : 0.05 g | 0.35 mL | Not calculated |
Non-medicinal ingredients
Eau purifiée, Ethanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Cuillère à thé | 3 days |
Uses authorised in Canada
Used in herbal medicine as a diuretic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a healthcare practitioner prior to use if you are breastfeeding or if you have gallstones. Hypersensitivity (allergy of Birch) has been known to occur; in which case, discontinue use.
- Contre-indications
Do not use if you are pregnant or if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. Do not take this product if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Consult a healthcare practitioner prior to use if you have oedema due to a kidney or cardiovascular or liver disorder, renal failure, on irrigation therapy. Consult a healthcare practitioner prior to use if you have anaemia, hiatus hernia or gastroesophageal reflux.
Source
Official Health Canada record, licence 80041815
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.